INS and Hypoglycemia: Instead, some agents that are available to be added to the increasing insulin dosage also have a potential to increase insulin-related hypoglycemia and weight gain.[22] Therefore, we need an agent that can work independent of the β-cell, reduce HbA1c effectively without provoking hypoglycemia, and additionally counter weight gain arising out of progressive increase in insulin dose.